ClinicalTrials.gg
CompletedNCT03498872Updated Apr 17, 2018

Strategic Research Program 17 (VUB Funding)

An interventional study of AMPfoot 4.0 and No intervention in Prosthesis User and Amputation; Traumatic, Limb, Lower, sponsored by Vrije Universiteit Brussel. Completed at 1 site in Belgium. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-17.

Sponsored by Vrije Universiteit Brussel · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled Oct 2016, registered Apr 2018).
Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

Objectives: The main objectives are to determine neural dynamics during gait using electro-encephalography as well as brain sources and to investigate the attentional demand during walking in able-bodied individuals, and individuals with an amputation.

Materials \& Methods: 6 able-bodied individuals conducted one experimental trial, and 6 unilateral transtibial and 6 unilateral transfemoral amputees performed 2 experimental trials; the first with the current and the second with a novel powered transtibial prosthesis, i.e. the Ankle Mimicking Prosthetic foot 4.0. Each experimental trial comprised 2 walking tasks; 6 and 2min treadmill walking at normal speed interspersed by 5min of rest. During 6min walking the sustained attention to response (go-no go) task, with measures reaction time and accuracy, was performed. Electro-encephalographic (EEG) data were gathered when subjects walked 2min. Motor-related cortical potentials and brain activity during gait are extracted using EEG.

Read the detailed description

Detailed description of the novel device:

The device mainly distinguishes itself from commercial prostheses thanks to its new type of actuation providing a compact and energy efficient solution to the challenge of ankle-foot actuation. This new actuation method consists of using springs, a servo motor and a locking mechanism, coupled with a sensory network providing intelligence to the robotic device. The AMPfoot 4.0 design is also based on previous research conducted on the AMP-Foot 2. However, it is important to note that in contrast with its preceding designs, the AMP-Foot 4.0 does not provide active propulsion at push-off.

During walking, the AMP-Foot 4.0 working principle is divided into two main logic sequences, i.e. the stance and the swing phase. These two phases are detected by analyzing gyroscope and acceleration measurements from an Inertial Measurement Unit chip. During the stance phase, the ankle performs a dorsi-flexing movement while a plantar-flexing torque is applied at the ankle. The person's gravitational potential energy is stored into elastic potential energy by means of the used spring. It is this spring that provides the plantar-flexing torque required at the ankle as reaction to the movement of the user. Due to the use of a locking system, the prosthesis can adapt its so-called zero torque rest point depending on the slope or stride length of the user. This provides adaptability and therefore greater comfort compared to prostheses with a fixed zero torque rest point. During the swing phase, the locking mechanism unlocks to free the ankle movement. Parallel springs external to the stance system are then activated to reset the foot to its initial position. From that moment, the device is ready for a new step.

02

Conditions studied

  • Prosthesis User
  • Amputation; Traumatic, Limb, Lower

Browse trials for

Keywords

  • AMPfoot
  • Prosthetics
  • gait
  • electro-encephalography
  • dual-task walking
03

In context

Amputation, Traumatic

112 studies on the registry are indexed under Amputation, Traumatic; 24 are open to participants now.

This study's enrollment of 18 is above the median of 15 across 75 interventional studies indexed under Amputation, Traumatic.

Browse Amputation, Traumatic studies →

Lead sponsor

Vrije Universiteit Brussel is the lead sponsor of 158 studies on the registry; 43 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Unilateral transfemoral amputees
  • Unilateral transtibial amputees
  • Able-bodied individuals

Exclusion criteria

Exclusion Criteria:

  • Children
  • Functional k-level lower than 4 (Amputee has the ability for prosthetic ambulation that exceeds basic ambulation skills, exhibiting high impact, stress or energy levels)
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
18 participants (actual)

Study arms

  • Active comparator
    Able-bodied individuals

    Other: No intervention

  • Experimental
    Transtibial amputee

    Device: AMPfoot 4.0

  • Experimental
    Transfemoral amputee

    Device: AMPfoot 4.0

Interventions

  • DeviceAMPfoot 4.0

    The novel prosthetic device, i.e. AMPfoot 4.0, was tested during walking in amputees. A dual-task was conducted and non-invasive electro-encephalography was used to investigate neural dynamics.

  • OtherNo intervention

    The control group included healthy subjects. Comparisons were made between amputees and able-bodied individuals.

06

What researchers measure

Primary outcomes

  1. Reaction time (in ms) of responses during go - no go cognitive task

    Time between visual stimulus and motor response (pushing button)

    Time frame: Through study completion, a period of 2 months

  2. Accuracy (in percentage) of correct responses during go - no go cognitive task

    Accuracy of motor responses to visual stimuli

    Time frame: Through study completion, a period of 2 months

  3. EEG extracted brain signals, i.e. motor-related cortical potentials

    Non-invasive electro-encephalography was used to determine electro-cortical potentials and brain sources of these potentials

    Time frame: Through study completion, a period of 2 months

07

Study locations

1 site
  • Vrije Universiteit Brussel
    Brussel, Vlaams Brabant 1050, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 17, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03498872
Responsible party
Romain Meeusen (Prof. Dr., Vrije Universiteit Brussel) — Principal investigator
First posted
Apr 17, 2018
Start date
Oct 1, 2016
Primary completion
Dec 15, 2016
Completion
Dec 15, 2016
Last update
Apr 17, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion